Safety of sinopharm COVID-19 vaccine in children and adolescents aged 5 to 18 years: a cohort event monitoring study
Sinopharm is a safe and well-tolerated vaccine option for children and adolescents and can be recommended for this population.
Authors
- Sepideh Mahdavi (ORCID: https://orcid.org/0000-0003-2161-5496)
- Alireza Ansari‐Moghaddam (ORCID: https://orcid.org/0000-0002-3267-7193)
- Sairan Nili (ORCID: https://orcid.org/0000-0001-9701-9792)
- Mohammad Hassan Emamian (ORCID: https://orcid.org/0000-0002-1994-1105)
- Parvin Mangolian Shahrbabaki (ORCID: https://orcid.org/0000-0003-0539-5390)
- Mostafa Enayatrad (ORCID: https://orcid.org/0000-0003-3465-3715)
- Hamidreza Khajeha (ORCID: https://orcid.org/0000-0003-2149-927X)
- Mansooreh Fateh (ORCID: https://orcid.org/0000-0001-7930-4637)
- Roqayeh Aliyari (ORCID: https://orcid.org/0000-0003-0627-585X)
- Mohammad Fereidouni (ORCID: https://orcid.org/0000-0002-2576-9452)
- Elahe Behmanesh
- Hamid Pour Sharifi (ORCID: https://orcid.org/0000-0002-9008-7618)
- Zahra Emamian
- Sajad Sahab Negah (ORCID: https://orcid.org/0000-0002-2242-9794)
Institutions
- Kerman University of Medical Sciences (IR)
- Kurdistan University of Medical Sciences (IR)
- Zahedan University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
- Shahroud University of Medical Sciences (IR)
- Birjand University of Medical Sciences (IR)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1186/s12889-025-25308-1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- World Health Organization
- Ministry of Health and Medical Education
- Shahroud University of Medical Sciences
- Vice Chancellor for Research and Technology, Kerman University of Medical Sciences